Hudson Bay Capital Management
NVS icon

Hudson Bay Capital Management’s Novartis NVS Stock Holding History

Hudson Bay Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-400,000
Closed -$42.6M – 986
2024
Q2 		$42.6M Buy
+400,000
New +$40.2M 0.2% 77

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hudson Bay Capital Management's NVS Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 114,346 shares — an estimated $15.8M sold.

Hudson Bay Capital Management first reported a position in NVS in Q4 2024 and held it in 3 quarters. The position peaked at $25.8M in Q1 2025. 1,597 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Hudson Bay Capital Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 114,346 Novartis shares in Q1 2026, an estimated $15.8M.
  • Hudson Bay Capital Management first reported a position in Novartis in Q4 2024 and held it in 3 quarters.
  • Hudson Bay Capital Management's Novartis position peaked at $25.8M in Q1 2025.
  • 1,597 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.